Longevity Diet

Researchers unmask a gene that protects C. elegans from lifespan-shrinking metabolic byproducts.

Written byRina Shaikh-Lesko
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ACCELERATED AGING: C. elegans whose alh-6 gene is impaired cannot convert 1-pyrroline-5-carboxylate (P5C) to glutamate, but the impact of this defect differs depending on diet. Worms fed the E. coli strain HT115 maintain low activity levels of PRODH, an enzyme that converts proline to P5C. In worms fed OP50 E. coli, PRODH activity increases, leading to an accumulation of P5C. These worms die sooner, perhaps because of an associated increase in reactive oxygen species.© KIMBERLY BATTISTA

The paper
S. Pang, S.P. Curran, “Adaptive capacity to bacterial diet modulates aging in C. elegans,” Cell Metabolism, 19:221-31, 2014.

Evidence that diet can profoundly affect aging is beginning to emerge, sometimes through targeted studies and other times by accident. While breeding mutant C. elegans worms for an unrelated experiment, Sean Curran and Shanshan Pang, a pair of researchers who study aging at the University of Southern California, noticed that certain mutant worms had considerably shorter life spans depending on their diet. The findings led the two to uncover a compensatory molecular mechanism for dealing with different menu items.

In the lab, C. elegans feeds on a variety of E. coli strains—most commonly, the B strain OP50 and the K-12 strain HT115. In an initial ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies